Related Experiment Video
Updated: Feb 22, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA-30e Functions as a Tumor Suppressor in Cervical Carcinoma Cells through Targeting GALNT7
Huijuan Wu1, Jun Chen2, Dan Li1
1Department of Gynecological Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, PR China.
Abstract:
Cervical cancer is the third most common cancer in women worldwide. However, the underlying mechanism of occurrence and development of cervical cancer is obscure. In this study, we observed that miR-30e was downregulated in clinical cervical cancer tissues and cervical cancer cells. Next, overexpression of miR-30e reduced the cervical cancer cell growth through MTT, colony formation, EdU, and Transwell assay in SiHa and Caski cells. Subsequently, UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7) was identified as a potential miR-30e target by bioinformatics analysis. Moreover, we showed that miR-30e was able to bind to the 3'UTR of GALNT7 by luciferase reporter assay. In addition, the mRNA and protein levels of GALNT7 in cervical cancer cells were downregulated by miR-30e. And we validated that downregulation of GALNT7 repressed the proliferation of SiHa and Caski cells by MTT, colony formation, and Transwell assay. We identified that the restoration of GALNT7 expression was able to counteract the effect of miR-30e on cell proliferation of cervical cancer cells. Furthermore, we found that the expression levels of GALNT7 were frequently upregulated and negatively correlative to those of miR-30e in cervical cancer tissues. In addition, we validated that restoration of GALNT7 rescued the miR-30e-suppressed growth of cervical cancer xenografts in vivo. In conclusion, the current results suggest that miR-30e may function as tumor suppressors in cervical cancer through downregulation of GALNT7. Both miR-30e and its novel target, GALNT7, may play an important role in the process of cervical cancer.
Insights
MicroRNA-30e (miR-30e) acts as a tumor suppressor in cervical cancer by downregulating GALNT7, inhibiting cancer cell growth and xenograft development. This highlights miR-30e and GALNT7 as key players in cervical cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cervical cancer is a significant global health concern, with its developmental mechanisms remaining unclear.
- MicroRNAs (miRNAs) are increasingly recognized for their roles in various cancers, including cervical cancer.
Purpose of the Study:
- To investigate the role of miR-30e in cervical cancer.
- To identify and validate the target gene of miR-30e involved in cervical cancer progression.
Main Methods:
- Analysis of miR-30e expression in clinical cervical cancer tissues and cell lines.
- Overexpression of miR-30e and assessment of its effects on cell proliferation using MTT, colony formation, EdU, and Transwell assays.
- Bioinformatic analysis and luciferase reporter assays to identify and confirm GALNT7 as a direct target of miR-30e.
- Validation of GALNT7 expression in cervical cancer tissues and its correlation with miR-30e levels.
- In vivo studies using cervical cancer xenografts to evaluate the therapeutic potential of miR-30e.
Main Results:
- miR-30e was found to be downregulated in cervical cancer tissues and cells.
- Overexpression of miR-30e significantly inhibited cervical cancer cell proliferation and growth.
- UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7) was identified as a direct target of miR-30e.
- Downregulation of GALNT7 by miR-30e repressed cervical cancer cell proliferation.
- GALNT7 expression was upregulated and inversely correlated with miR-30e levels in cervical cancer tissues.
- Restoration of GALNT7 expression counteracted the anti-proliferative effects of miR-30e in vitro and in vivo.
Conclusions:
- miR-30e functions as a tumor suppressor in cervical cancer by targeting and downregulating GALNT7.
- The miR-30e/GALNT7 axis plays a critical role in the development and progression of cervical cancer.
- Both miR-30e and GALNT7 represent potential therapeutic targets for cervical cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

